- Corporate Officers - D
- Drachman Jonathan G
Insider Trading History of Drachman Jonathan G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Drachman Jonathan G since 2014.
This trader's CIK number is 1588467.
At the time of last reporting, Drachman Jonathan G was the Director of Calithera Biosciences, Inc.. (stock ticker symbol CALA).
Also see all insider trading activities at Calithera Biosciences, Inc..
Note that in the past
DRACHMAN JONATHAN G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Neoleukin Therapeutics, Inc. (NLTX) by Drachman Jonathan G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | NLTX | 200,000 | $1,408,910 | 0 | $0 | 0 | $0 |
| 2019 | NLTX | 369,047 | $1,781,792 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Calithera Biosciences, Inc. (CALA) by Drachman Jonathan G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CALA | 200,000 | $172,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seagen Inc. (SGEN) by Drachman Jonathan G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | SGEN | 0 | $0 | 10,457 | $553,279 | 60,912 | $811,149 |
| 2017 | SGEN | 0 | $0 | 38,502 | $2,070,872 | 52,816 | $561,235 |
| 2016 | SGEN | 0 | $0 | 17,409 | $1,007,800 | 15,000 | $160,549 |
| 2015 | SGEN | 0 | $0 | 4,462 | $187,511 | 0 | $0 |
| 2014 | SGEN | 0 | $0 | 5,214 | $241,745 | 0 | $0 |
Insider trading activities at 3 companies by Drachman Jonathan G:
1. Neoleukin Therapeutics, Inc. (NLTX)
2. Calithera Biosciences, Inc. (CALA)
3. Seagen Inc. (SGEN)
Table 1. Insider trading of Neoleukin Therapeutics, Inc. (NLTX) by Drachman Jonathan G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-08-24 | NLTX | Buy | 100,000 | 6.11 | 611,100 |
| 2021-08-25 | NLTX | Buy | 50,000 | 6.45 | 322,450 |
| 2021-06-03 | NLTX | Buy | 40,000 | 9.48 | 379,280 |
| 2021-06-04 | NLTX | Buy | 10,000 | 9.61 | 96,080 |
| 2019-12-20 | NLTX | Buy | 119,047 | 8.40 | 999,994 |
| 2019-09-11 | NLTX | Buy | 136,436 | 3.30 | 449,965 |
| 2019-09-10 | NLTX | Buy | 36,742 | 3.08 | 113,275 |
| 2019-09-09 | NLTX | Buy | 76,822 | 2.85 | 218,558 |
Table 2. Insider trading of Calithera Biosciences, Inc. (CALA) by Drachman Jonathan G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-10 | CALA | Buy | 200,000 | .86 | 172,000 |
Table 3. Insider trading of Seagen Inc. (SGEN) by Drachman Jonathan G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-20 | SGEN | Option Ex | 31,039 | 16.04 | 497,958 |
| 2018-03-05 | SGEN | Option Ex | 10,457 | 8.96 | 93,694 |
| 2018-03-05 | SGEN | Sale | 10,457 | 52.91 | 553,279 |
| 2018-01-11 | SGEN | Option Ex | 19,416 | 11.30 | 219,497 |
| 2017-10-05 | SGEN | Option Ex | 17,816 | 11.29 | 201,089 |
| 2017-08-28 | SGEN | Sale | 8,502 | 47.90 | 407,203 |
| 2017-08-24 | SGEN | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-08-24 | SGEN | Sale | 10,000 | 47.54 | 475,409 |
| 2017-07-27 | SGEN | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-07-27 | SGEN | Sale | 10,000 | 54.54 | 545,360 |
| 2017-06-22 | SGEN | Option Ex | 10,000 | 10.29 | 102,899 |
| 2017-06-22 | SGEN | Sale | 10,000 | 64.29 | 642,900 |
| 2017-01-25 | SGEN | Option Ex | 5,000 | 10.29 | 51,449 |
| 2016-11-09 | SGEN | Option Ex | 7,751 | 11.09 | 85,958 |
| 2016-11-09 | SGEN | Sale | 7,751 | 66.75 | 517,379 |
| 2016-11-01 | SGEN | Sale | 3,418 | 51.74 | 176,847 |
| 2016-09-22 | SGEN | Sale | 2,249 | 56.75 | 127,630 |
| 2016-09-22 | SGEN | Option Ex | 2,249 | 10.29 | 23,142 |
| 2016-08-22 | SGEN | Sale | 3,991 | 46.59 | 185,944 |
| 2016-06-02 | SGEN | Option Ex | 5,000 | 10.29 | 51,449 |
| 2015-08-20 | SGEN | Sale | 4,462 | 42.02 | 187,511 |
| 2014-08-24 | SGEN | Sale | 2,772 | 43.55 | 120,717 |
| 2014-02-20 | SGEN | Sale | 1,241 | 53.25 | 66,083 |
| 2014-01-16 | SGEN | Sale | 1,201 | 45.75 | 54,945 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Drachman Jonathan G
(Director of Calithera Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.